• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型的人体组织工程三维功能性血管化心肌构建物。

A Novel Human Tissue-Engineered 3-D Functional Vascularized Cardiac Muscle Construct.

作者信息

Valarmathi Mani T, Fuseler John W, Davis Jeffrey M, Price Robert L

机构信息

Laboratory of Stem Cell Biology and Tissue Engineering, Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois at Urbana-Champaign Urbana, IL, USA.

Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina Columbia, SC, USA.

出版信息

Front Cell Dev Biol. 2017 Jan 30;5:2. doi: 10.3389/fcell.2017.00002. eCollection 2017.

DOI:10.3389/fcell.2017.00002
PMID:28194397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5276820/
Abstract

Organ tissue engineering, including cardiovascular tissues, has been an area of intense investigation. The major challenge to these approaches has been the inability to vascularize and perfuse the engineered tissue constructs. Attempts to provide oxygen and nutrients to the cells contained in the biomaterial constructs have had varying degrees of success. The aim of this current study is to develop a three-dimensional (3-D) model of vascularized cardiac tissue to examine the concurrent temporal and spatial regulation of cardiomyogenesis in the context of postnatal vasculogenesis during stem cell cardiac regeneration. In order to achieve the above aim, we have developed an 3-D functional vascularized cardiac muscle construct using human induced pluripotent stem cell-derived embryonic cardiac myocytes (hiPSC-ECMs) and human mesenchymal stem cells (hMSCs). First, to generate the prevascularized scaffold, human cardiac microvascular endothelial cells (hCMVECs) and hMSCs were co-cultured onto a 3-D collagen cell carrier (CCC) for 7 days under vasculogenic culture conditions. In this milieu, hCMVECs/hMSCs underwent maturation, differentiation, and morphogenesis characteristic of microvessels, and formed extensive plexuses of vascular networks. Next, the hiPSC-ECMs and hMSCs were co-cultured onto this generated prevascularized CCCs for further 7 or 14 days in myogenic culture conditions. Finally, the vascular and cardiac phenotypic inductions were analyzed at the morphological, immunological, biochemical, molecular, and functional levels. Expression and functional analyses of the differentiated cells revealed neo-angiogenesis and neo-cardiomyogenesis. Thus, our unique 3-D co-culture system provided us the apt functional vascularized 3-D cardiac patch that can be utilized for cellular cardiomyoplasty.

摘要

包括心血管组织在内的器官组织工程一直是一个深入研究的领域。这些方法面临的主要挑战是无法使工程化组织构建体血管化并进行灌注。为生物材料构建体中所含细胞提供氧气和营养物质的尝试取得了不同程度的成功。本研究的目的是建立一种血管化心脏组织的三维(3-D)模型,以研究干细胞心脏再生过程中出生后血管生成背景下心肌发生的同时时空调节。为了实现上述目标,我们使用人诱导多能干细胞衍生的胚胎心肌细胞(hiPSC-ECM)和人间充质干细胞(hMSC)开发了一种三维功能性血管化心肌构建体。首先,为了生成预血管化支架,将人心脏微血管内皮细胞(hCMVEC)和hMSC在血管生成培养条件下共培养在三维胶原细胞载体(CCC)上7天。在这种环境中,hCMVEC/hMSC经历了微血管特有的成熟、分化和形态发生,并形成了广泛的血管网络丛。接下来,将hiPSC-ECM和hMSC在肌源性培养条件下共培养在这种生成的预血管化CCC上7天或14天。最后,在形态学、免疫学、生物化学、分子和功能水平上分析血管和心脏表型诱导。分化细胞的表达和功能分析显示了新血管生成和新心肌生成。因此,我们独特的三维共培养系统为我们提供了适合用于细胞心肌成形术的功能性血管化三维心脏补片。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/a4a64fb6f884/fcell-05-00002-g0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/71e05a99dd6c/fcell-05-00002-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/bbb4cf96dad7/fcell-05-00002-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/7da994474925/fcell-05-00002-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/b7470c72b7d0/fcell-05-00002-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/8527d08df30e/fcell-05-00002-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/260ad590364e/fcell-05-00002-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/1de3783112a0/fcell-05-00002-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/914239d87d95/fcell-05-00002-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/3ee3a04be33e/fcell-05-00002-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/151cd0b5de55/fcell-05-00002-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/211cf873a7ee/fcell-05-00002-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/24fd79655fbf/fcell-05-00002-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/a4a64fb6f884/fcell-05-00002-g0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/71e05a99dd6c/fcell-05-00002-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/bbb4cf96dad7/fcell-05-00002-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/7da994474925/fcell-05-00002-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/b7470c72b7d0/fcell-05-00002-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/8527d08df30e/fcell-05-00002-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/260ad590364e/fcell-05-00002-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/1de3783112a0/fcell-05-00002-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/914239d87d95/fcell-05-00002-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/3ee3a04be33e/fcell-05-00002-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/151cd0b5de55/fcell-05-00002-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/211cf873a7ee/fcell-05-00002-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/24fd79655fbf/fcell-05-00002-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b04/5276820/a4a64fb6f884/fcell-05-00002-g0013.jpg

相似文献

1
A Novel Human Tissue-Engineered 3-D Functional Vascularized Cardiac Muscle Construct.一种新型的人体组织工程三维功能性血管化心肌构建物。
Front Cell Dev Biol. 2017 Jan 30;5:2. doi: 10.3389/fcell.2017.00002. eCollection 2017.
2
Functional Tissue Engineering: A Prevascularized Cardiac Muscle Construct for Validating Human Mesenchymal Stem Cells Engraftment Potential In Vitro.功能性组织工程:用于体外验证人骨髓间充质干细胞移植潜能的预血管化心肌构建体
Tissue Eng Part A. 2018 Jan;24(1-2):157-185. doi: 10.1089/ten.TEA.2016.0539. Epub 2017 May 25.
3
Construction of a vascularized hydrogel for cardiac tissue formation in a porcine model.构建用于在猪模型中形成心脏组织的血管化水凝胶。
J Tissue Eng Regen Med. 2018 Apr;12(4):e2029-e2038. doi: 10.1002/term.2634. Epub 2018 Jan 10.
4
Preparation of three-dimensional vascularized MSC cell sheet constructs for tissue regeneration.三维血管化 MSC 细胞片层构建物用于组织再生。
Biomed Res Int. 2014;2014:301279. doi: 10.1155/2014/301279. Epub 2014 Jul 8.
5
A 3-D cardiac muscle construct for exploring adult marrow stem cell based myocardial regeneration.用于探索基于成体骨髓干细胞的心肌再生的 3D 心脏肌组织构建体。
Biomaterials. 2010 Apr;31(12):3185-200. doi: 10.1016/j.biomaterials.2010.01.041. Epub 2010 Feb 2.
6
Co-Seeding Human Endothelial Cells with Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells on Calcium Phosphate Scaffold Enhances Osteogenesis and Vascularization in Rats.在磷酸钙支架上共同接种人诱导多能干细胞衍生的间充质干细胞与人内皮细胞可增强大鼠的成骨作用和血管生成。
Tissue Eng Part A. 2017 Jun;23(11-12):546-555. doi: 10.1089/ten.tea.2016.0485. Epub 2017 Mar 10.
7
Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.羊膜作为人诱导多能干细胞来源心肌生成的新型支架。
In Vitro Cell Dev Biol Anim. 2019 Apr;55(4):272-284. doi: 10.1007/s11626-019-00321-y. Epub 2019 Feb 24.
8
A three-dimensional model of vasculogenesis.血管生成的三维模型。
Biomaterials. 2009 Feb;30(6):1098-112. doi: 10.1016/j.biomaterials.2008.10.044. Epub 2008 Nov 22.
9
Functional 3-D cardiac co-culture model using bioactive chitosan nanofiber scaffolds.使用生物活性壳聚糖纳米纤维支架构建功能性 3D 心脏共培养模型。
Biotechnol Bioeng. 2013 Feb;110(2):637-47. doi: 10.1002/bit.24727. Epub 2012 Oct 5.
10
Enhanced elastin synthesis and maturation in human vascular smooth muscle tissue derived from induced-pluripotent stem cells.源自诱导多能干细胞的人血管平滑肌组织中弹性蛋白合成与成熟的增强。
Acta Biomater. 2017 Apr 1;52:49-59. doi: 10.1016/j.actbio.2017.01.083. Epub 2017 Feb 3.

引用本文的文献

1
Fetal adnexa-derived allogeneic mesenchymal stem cells for cardiac regeneration: the future trend of cell-based therapy for age-related adverse conditions.用于心脏再生的胎儿附件来源的同种异体间充质干细胞:基于细胞治疗年龄相关不良状况的未来趋势。
Hum Cell. 2025 Feb 25;38(2):61. doi: 10.1007/s13577-025-01190-2.
2
Recent Advances on Cell-Based Co-Culture Strategies for Prevascularization in Tissue Engineering.基于细胞的组织工程预血管化共培养策略的最新进展
Front Bioeng Biotechnol. 2021 Nov 25;9:745314. doi: 10.3389/fbioe.2021.745314. eCollection 2021.
3
Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy.

本文引用的文献

1
Evaluation of a thin and mechanically stable collagen cell carrier.一种薄且机械稳定的胶原细胞载体的评估。
Tissue Eng Part C Methods. 2011 Dec;17(12):1161-70. doi: 10.1089/ten.TEC.2011.0201. Epub 2011 Sep 14.
2
The mechanical coupling of adult marrow stromal stem cells during cardiac regeneration assessed in a 2-D co-culture model.二维共培养模型评估心脏再生过程中成年骨髓基质干细胞的机械偶联。
Biomaterials. 2011 Apr;32(11):2834-50. doi: 10.1016/j.biomaterials.2011.01.012. Epub 2011 Feb 1.
3
A 3-D cardiac muscle construct for exploring adult marrow stem cell based myocardial regeneration.
工程化心脏组织:一种用于研究小鼠糖尿病心肌病病理生理学的新型体外模型。
Acta Pharmacol Sin. 2021 Jun;42(6):932-941. doi: 10.1038/s41401-020-00538-8. Epub 2020 Oct 9.
4
Cell-derived extracellular matrix-coated silk fibroin scaffold for cardiogenesis of brown adipose stem cells through modulation of TGF-β pathway.细胞衍生的细胞外基质包被的丝素蛋白支架通过调节TGF-β信号通路促进棕色脂肪干细胞向心肌细胞分化
Regen Biomater. 2020 Aug;7(4):403-412. doi: 10.1093/rb/rbaa011. Epub 2020 Apr 24.
5
Innervation: the missing link for biofabricated tissues and organs.神经支配:生物制造组织和器官的缺失环节。
NPJ Regen Med. 2020 Jun 5;5:11. doi: 10.1038/s41536-020-0096-1. eCollection 2020.
6
Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.人多能干细胞源性心脏基质细胞及其在再生医学中的应用。
Stem Cell Res. 2020 May;45:101831. doi: 10.1016/j.scr.2020.101831. Epub 2020 Apr 27.
7
Bioengineering human vascular networks: trends and directions in endothelial and perivascular cell sources.生物工程化人类血管网络:内皮细胞和血管周细胞来源的趋势与方向。
Cell Mol Life Sci. 2019 Feb;76(3):421-439. doi: 10.1007/s00018-018-2939-0. Epub 2018 Oct 12.
8
Engineered circulatory scaffolds for building cardiac tissue.用于构建心脏组织的工程循环支架。
J Thorac Dis. 2018 Jul;10(Suppl 20):S2312-S2328. doi: 10.21037/jtd.2017.12.92.
9
Engineering a microcirculation for perfusion control of ex vivo-assembled organ systems: Challenges and opportunities.构建用于体外组装器官系统灌注控制的微循环:挑战与机遇
J Tissue Eng. 2018 May 10;9:2041731418772949. doi: 10.1177/2041731418772949. eCollection 2018 Jan-Dec.
10
Integrated approaches to spatiotemporally directing angiogenesis in host and engineered tissues.时空引导宿主和工程组织血管生成的综合方法。
Acta Biomater. 2018 Mar 15;69:42-62. doi: 10.1016/j.actbio.2018.01.017. Epub 2018 Jan 31.
用于探索基于成体骨髓干细胞的心肌再生的 3D 心脏肌组织构建体。
Biomaterials. 2010 Apr;31(12):3185-200. doi: 10.1016/j.biomaterials.2010.01.041. Epub 2010 Feb 2.
4
The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.MIQE指南:实时定量PCR实验发表的最低信息要求
Clin Chem. 2009 Apr;55(4):611-22. doi: 10.1373/clinchem.2008.112797. Epub 2009 Feb 26.
5
A three-dimensional model of vasculogenesis.血管生成的三维模型。
Biomaterials. 2009 Feb;30(6):1098-112. doi: 10.1016/j.biomaterials.2008.10.044. Epub 2008 Nov 22.
6
Standardization of real-time PCR gene expression data from independent biological replicates.来自独立生物学重复样本的实时PCR基因表达数据的标准化
Anal Biochem. 2008 Aug 1;379(1):127-9. doi: 10.1016/j.ab.2008.04.036. Epub 2008 Apr 26.
7
A three-dimensional tubular scaffold that modulates the osteogenic and vasculogenic differentiation of rat bone marrow stromal cells.一种可调节大鼠骨髓基质细胞成骨和血管生成分化的三维管状支架。
Tissue Eng Part A. 2008 Apr;14(4):491-504. doi: 10.1089/tea.2007.0235.
8
The influence of proepicardial cells on the osteogenic potential of marrow stromal cells in a three-dimensional tubular scaffold.心外膜前体细胞对三维管状支架中骨髓基质细胞成骨潜能的影响。
Biomaterials. 2008 May;29(14):2203-16. doi: 10.1016/j.biomaterials.2008.01.025. Epub 2008 Mar 4.
9
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.定义多能间充质基质细胞的最低标准。国际细胞治疗协会立场声明。
Cytotherapy. 2006;8(4):315-7. doi: 10.1080/14653240600855905.
10
Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step .干细胞疗法对患者来说准备好了吗?用于心脏修复的干细胞疗法。准备好迈向下一步了。
Circulation. 2006 Jul 25;114(4):339-52. doi: 10.1161/CIRCULATIONAHA.105.590653.